KIO-104
KIO-104-2100
Phase 2 small_molecule active
Quick answer
KIO-104 for Macular Edema is a Phase 2 program (small_molecule) at KIORA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KIORA PHARMACEUTICALS INC
- Indication
- Macular Edema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active